triazoles has been researched along with Recrudescence in 136 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (2.94) | 18.7374 |
1990's | 17 (12.50) | 18.2507 |
2000's | 59 (43.38) | 29.6817 |
2010's | 50 (36.76) | 24.3611 |
2020's | 6 (4.41) | 2.80 |
Authors | Studies |
---|---|
Chalopin, T; Nsiala, L | 1 |
Chen, WY; Hung, SJ; Lin, SR | 1 |
Abd Eldaim, MA; Abdallah, AEM; Abdel-Daim, MM; Abdelaziz, SAM; Abdul Rashid, S; Abdullah, AS; Abdullah, LC; Abramson, MJ; Ahmed, HB; Ahmed, MM; Ahn, YC; Alexander, DC; Ando, T; Angelone, AM; Anglani, F; Ap, Y; Arthanari, SK; Axelrad, C; Bai, S; Bakonyi, P; Barnes, E; Beckmann, NA; Bélafi-Bakó, K; Bennett, CM; Bestha, RM; Bitsch, RG; Bradley, CA; Bu, Y; Calò, LA; Cañedo-Villaroya, E; Carlson, L; Caruso, S; Casado-Flores, J; Ceol, M; Cesarino, I; Chen, IL; Chen, R; Chen, X; Chilvers, MI; Cho, WK; Choong, TSY; Conceição-Neto, N; Culver, EL; Dai, X; de Lama Caro-Patón, G; De Rosa, I; Del Prete, D; Dharmage, SC; Dimitriadis, E; Dittakavi, S; Dobrowolski, JC; Edin, S; Elgarawany, GE; Emam, HE; Emmens, RW; Erbas, B; Erwich, JJHM; Farghali, M; Feng, L; Funston, RN; Gabler, NK; Gale, P; Ganesh, M; Gao, J; Gao, L; Gao, X; García-Salido, A; Gatto, R; Gautam, S; Ge, C; Ghogomu, SM; Gianesello, L; Gonçales, VR; Gooch, JL; Gooding, JJ; Gourley, GG; Gu, H; Gu, X; Gu, Z; Guerreri, M; Guillén, M; Hazzaa, SM; Heylen, E; Hicks, R; Hong, X; Hoshi, M; Hu, B; Hu, LX; Hu, R; Hu, S; Huang, J; Huang, K; Hubbard, WB; Hui, J; Hwang, NY; Iannacci, J; Ianus, A; Iglesias-Bouzas, MI; Ihara, I; Iwasaki, M; Jaeger, S; Kandel, YR; Karpińska, G; Kim, HK; Klopfenstein, TJ; Knorr, D; Koók, L; Kotb, S; Kruithof, S; Larsson, P; Laurence, C; Leng, J; Li, H; Li, J; Li, Q; Li, S; Li, X; Li, Z; Lian, J; Liang, JX; Liang, X; Lighaam, LC; Lin, CW; Lin, HC; Lin, J; Ling, A; Liu, J; Liu, P; Liu, YS; Ljuslinder, I; Lo, GH; Lodge, CJ; Löfgren-Burström, A; Lowe, AJ; Lu, M; Lu, N; Lucero-Prisno, DE; Luebbe, KM; Luo, X; Ma, Z; Maes, P; Makuch, M; Malekbala, MR; Mao, Z; Martínez-Romera, I; Marzo, G; Mathew, FM; Mattei, A; Matthijnssens, J; Mayumi, M; Morita, N; Mueller, DS; Mullangi, R; Mummolo, S; Murthi, P; Myte, R; Nabeshima, T; Nakamoto, K; Nehdi, IA; Nemestóthy, N; Niessen, HWM; Noh, JM; Nota, A; Nunes, D; Oh, D; Öhlund, D; Olsen, KM; Ono, H; Osawa, Y; Palmqvist, R; Palombo, M; Park, M; Patience, JF; Peng, Y; Perng, DS; Persano, A; Priante, G; Prince, SJ; Pulipati, S; Pyo, H; Qiu, X; Quan, J; Quaranta, F; Quinzi, V; Rademacher, CJ; Rajaraman, G; Rashid, U; Rauch, JC; Rector, A; Remmerswaal, EBM; Ren, R; Rispens, T; Rocha, GS; Saad, NM; Saito, K; Salamova, A; Sarfaraz, K; Satoshi, A; Schnellmann, RG; Scholpa, NE; Schonhoff, M; Schwartz, KJ; Schwarze, M; Schweer, WP; Seiichi, Y; Serrano-González, A; Severino, J; Shemesh, N; Shi, ZQ; Shike, DW; Shim, YM; Siciliano, PA; Siebenrock, KA; Silva, MKL; Smith, DL; Soltani, S; Song, YM; Spry, ML; Stalker, LA; Stokes, RS; Sullivan, PG; Sun, JM; Sun, S; Svanes, C; Syo, K; Tai, CM; Takashima, S; Tashita, C; Taurino, A; Ten Berge, IJM; Tenuta, AU; Teo, SH; Tilley, RD; Trivedi, RK; Umetsu, K; Unger, PA; van Bruggen, R; van Ham, SM; Van Ranst, M; Vanitha, J; Vekaria, HJ; Venier, M; Venkateshwaran, K; Venkert, A; Vermeulen, E; Wan, C; Wang, H; Wang, N; Wang, P; Wang, T; Wang, X; Wang, Y; Wise, KA; Wolbink, GJ; Wu, J; Wu, P; Wu, S; Wu, Y; Xia, Q; Xin, W; Xiong, Q; Xu, H; Xu, P; Xue, S; Yamamoto, Y; Yamashiro, T; Yan, F; Yan, H; Yan, S; Yan, Y; Yang, JM; Yang, L; Yang, P; Ye, W; Yeh, JH; Yinda, CK; Ying, GG; Ying, L; Yoon, HG; Yu, H; Zainuddin, M; Zakkula, A; Zeller, M; Zeng, Y; Zha, J; Zhang, F; Zhang, H; Zhang, M; Zhang, Q; Zhang, S; Zhang, T; Zhang, Z; Zhao, C; Zhao, J; Zhao, Y; Zhong, Q; Zhu, J; Zingmark, C; Zo, JI; Zou, Y | 1 |
Cheah, R; Dendle, C; Gregory, G; Mohan, B; Tey, A | 1 |
Amberg, S; Bokemeyer, C; Christine Wilke, A; Chromik, J; Deppermann, U; Fiedler, W; Ganser, A; Heuser, M; Janning, M; Kebenko, M; Kranich, AL; Modemann, F; Schlipfenbacher, V; Serve, H; Theile, S; Thol, F | 1 |
Abdul-Hamil, NA; Cherchione, C; Martinelli, G; Nagarajan, C; Wong, GC | 1 |
DeMari, S; Hassan, H; Hughes, DM; Sanchorawala, V; Sloan, JM | 1 |
Abid, H; Abid, MB; Wu, JF | 1 |
Pan, W; Sun, X; Tang, X; Wu, S; Yang, Y | 1 |
Banerjee, S; Della Pepa, C; George, A; Gore, M; Kaye, S; McLachlan, J; Migali, C; Tunariu, N | 1 |
Connolly, P; Montejano, R; Spec, A; Wheat, LJ | 1 |
Abdallah, N; Kanj, A; Soubani, AO | 1 |
Mountifield, R | 1 |
Fleming, ME; Gordon, WT; Jessie, EM; Khan, M; Malone, DL; Murray, CK; Potter, BK; Rodriguez, CJ; Shackelford, SA; Tribble, DR | 1 |
Almeida Oliveira, M; Carmo, A; Murta, J; Rosa, A | 1 |
Chari, A; Cole, CE; Hycner, T; Jakubowiak, AJ; Jasielec, JK; Karrison, T; McIver, A; Mikhael, J; Nam, J; Rosebeck, S; Rosenbaum, CA; Severson, E; Stephens, LA; Tinari, K; Turowski, A; Zimmerman, TM; Zonder, JA | 1 |
Barreto, JN; Beach, CL; Hogan, WJ; Litzow, MR; Merten, JA; Tosh, PK; Wilson, JW; Wolf, RC | 1 |
Bravo, F; Bustamante, B; Salomon, M; Seas, C | 1 |
Butler, J; Curley, C; Durrant, S; Kennedy, GA; Morris, KL; Subramonpillai, E | 1 |
Chaudry, MN; Park, BJ; Schaefer, MK; Smith, RM; Tipple, M | 1 |
Cataldo, C; D'Andrea, F; De Francesco, F; del Giudice, EM; Di Grezia, G; Ferraro, GA; Gatta, G; Grandone, A; Nicoletti, G; Perrone, L; Romano, T | 1 |
Labbadia, F; Sanchez-Salinas, A | 1 |
Adamski, Z; Gil, L; Komarnicki, M; Kubisiak-Michalska, A; Kubisiak-Rzepczyk, H; Mol, A; Reich, A; Zawirska, A | 1 |
Tosti, A | 1 |
Badoual, C; Devars Du Mayne, M; El Naderi, S; Rodriguez, C | 1 |
Brownell, I; Cowen, EW; De Ravin, SS; Lee, CC; Malech, HL; Turegano, MM | 1 |
Ando, T; Kawashima, M; Koyama, K; Matsui, H; Nagai, H; Ohshima, N; Ohta, K; Sato, R; Suzuki, J; Takeda, K | 1 |
Schiavon, G; Smith, IE; Yeo, B | 1 |
Egan, CG; Mogavero, S; Savi, L | 1 |
Glynne, R; Groessl, T; Khare, S; Liu, X; Molteni, V; Rivera, I; Stinson, M; Supek, F; Tuntland, T; Wen, B; Yeh, V | 1 |
Abdul Razak, AR; Bartha-Vári, JH; Boros, Z; Cai, S; Carlson, R; Chong, YS; Chua, SY; Dagis, A; Feng, X; Foo, VH; Gabrail, NY; Gerecitano, JF; Gluckman, P; Huber, S; Ikram, MK; Irimie, FD; Kauffman, M; Kim, R; Kwek, K; Landesman, Y; Lassen, U; Li, D; Li, Q; Liu, C; Ma, J; Mahipal, A; Mau-Soerensen, M; McCauley, D; Mirza, MR; Nademanee, A; Ngo, C; Paizs, C; Palmer, JM; Pizzari, T; Poppe, L; Rashal, T; Saint-Martin, JR; Saw, SM; Shacham, S; Shields, AF; Stayner, LA; Tan, CS; Thorborg, K; Toşa, MI; Tsai, NC; Unger, TJ; Verkicharla, PK; Vértessy, BG; Wang, S; Wang, Y; Weiser, D; Wollin, M; Wong, TY; Xu, L; Yuan, L; Yuan, S; Zhang, Y; Zheng, R | 1 |
Bhatia, N; Caldwell, B; Elewski, BE; Gupta, AK; Kircik, LH; Pariser, DM; Rosen, T; Tosti, A | 1 |
Beck, JT; Gelmon, K; Goss, PE; Gralow, J; Hudis, C; Ingle, JN; Kaur, JS; Muss, H; Parulekar, WR; Pritchard, KI; Robert, NJ; Rubin, S; Stopeck, A; Strasser-Weippl, K; Sturtz, K; Tu, D; Whelan, K; Whelan, T; Winer, E; Wolff, AC | 1 |
Chung, SJ; Hwang, WY; Tan, AL; Tan, BH; Tan, TT; Thien, SY | 1 |
Rosen, T | 1 |
Ananda-Rajah, MR; Grigg, A; Slavin, MA | 1 |
Ahmad, S; Al-Obaid, I; Al-Sweih, NA; Farhat, D; Joseph, L; Khan, ZU | 1 |
Cervera, C; Crespo, G; Marco, F; Michelena, J; Moreno, A; Navasa, M | 1 |
Grosshans, M; Kiefer, F; Mutschler, J | 1 |
Guggemos, W; Hecht, A; Rüdisser, K; Seilmaier, M | 1 |
Arnow, BA; Blalock, JA; Keitner, GI; Klein, DN; Maddux, RE; Manber, R; Markowitz, JC; Riso, LP; Rothbaum, BO; Thase, ME | 1 |
Cociglio, M; Eiden, C; Hansel-Esteller, S; Hillaire-Buys, D; Margueritte, G; Palenzuela, G; Peyriere, H | 1 |
Al-Badriyeh, D; Davies, GE; Kong, D; Leung, L; Stewart, K | 1 |
Jinta, E; Sakurai, T; Shimizu, S; Suzuma, T; Umemura, T; Yoshimura, G | 1 |
Oktay, K; Rodriguez-Wallberg, K; Schover, L | 1 |
Asticcioli, S; Daturi, R; Matti, C; Nucleo, E; Pagani, L; Sacco, L; Zara, F | 1 |
Sasson, IE; Taylor, HS | 1 |
Glück, S | 1 |
Berberoglu, M; Bilir, P; Engiz, O; Ocal, G; Siklar, Z | 1 |
Jensen, SG; Nielsen, TL | 1 |
Cooperstock, MS; Griffard, EA; Guajardo, JR; Scoville, CL | 1 |
Friedland, JS; Ind, PW; Nogueira, EL; Salama, AD | 1 |
Croxo, C; Mulliez, P; Saint-Georges, FR | 1 |
Charles, JF; Daikh, DI; Eberle, C; Rooney, T | 1 |
Bloomer, MM; Fintelmann, RE; Gilmer, W; Jeng, BH | 1 |
Anderson, H; Dowsett, M; Dunbier, AK; Ghazoui, Z; Parker, JS; Perou, CM; Salter, J; Smith, IE | 1 |
Dowsett, M; Dunbier, A; Ghazoui, Z; Johnston, S; Martin, LA; Pancholi, S; Weigel, MT | 1 |
Bjelic-Radisic, V; Dubsky, P; Fesl, C; Gnant, M; Greil, R; Königsberg, R; Marth, C; Mlineritsch, B; Pfeiler, G; Pöstlberger, S; Samonigg, H; Seifert, M; Singer, CF; Steger, GG; Stoeger, H; Taucher, S | 1 |
Chavala, SH; Ehlers, JP; Postel, EA; Woodward, JA | 1 |
Dunton, CJ; Sylvestre, VT | 1 |
Hamoud, S; Hayek, T; Keidar, Z | 1 |
Bergh, J; Brattström, D; Eiermann, W; Henriksson, R; Jönsson, PE; Lidbrink, EK; Lindemann, JP; Trudeau, M; Wiklund, F | 1 |
Hikino, H; Koike, M; Mukai, T; Murata, Y | 1 |
Biswas, J; Gopal, L; Selvakumar, P; Sofia, O | 1 |
Bartolesi, AM; Fanci, R; Pecile, P; Pini, G | 1 |
Cid Lama, A; Crespo Erchiga, V; Fernández Ballesteros, MD; Gomez-Moyano, E; Lova Navarro, M; Vera Casaño, A | 1 |
Atkinson, G; Lee, GA; McLintock, CA | 1 |
Buendía, B; Cuenca-Estrella, M; De La Camara, R; Mellado, E; Rodriguez-Tudela, JL | 1 |
Fiehler, J; Gerloff, C; Kruetzelmann, A; Rosenkranz, M; Sobottka, I; Tolosa, E | 1 |
Magee, PJ; Rowland, I | 1 |
Ehrentraut, S; Gerbes, AL; Kapfhammer, HP; Rau, HG; Rothenhäusler, HB; Schirren, CA; Thiel, M | 1 |
Cornely, OA; Karthaus, M; Ullmann, AJ | 1 |
Lines, CR; McCarroll, KA; Visser, WH | 1 |
Bacigalupo, A; Ferrua, MT; Gallamini, A; Ghirardo, D; Lo Nigro, C; Mattei, D; Mordini, N; Osenda, M; Viscoli, C | 1 |
Arnow, B; Banks, P; Borian, FE; Dunner, DL; Gelenberg, AJ; Hirschfeld, RM; Howland, R; Keitner, GI; Keller, MB; Klein, DN; Kocsis, JH; Kornstein, SG; Manber, R; Markowitz, JC; Miller, I; Munsaka, M; Rothbaum, B; Rush, AJ; Russell, JM; Thase, ME; Trivedi, MH; Zajecka, J | 1 |
Arnow, B; Blalock, JA; Borian, FE; Castonguay, LG; Keller, MB; Klein, DN; Manber, R; Markowitz, JC; McCullough, JP; Miller, IW; Riso, LP; Rothbaum, B; Santiago, NJ; Schwartz, JE; Thase, ME; Vivian, D; Vocisano, C | 1 |
Bastié, JN; Bretagne, S; Castaigne, S; Chehata, S; Cordonnier, C; Kuentz, M; Maury, S; Pautas, C; Ribaud, P | 1 |
Cady, R; Klipfel, M; Lewis, D; McCarroll, K; Nett, R; Peng, Y; Strohmaier, K; Visser, WH; Winner, P | 1 |
Healey, PJ; Mullins, CD; Perfetto, EM; Subedi, PR; Weis, KA | 1 |
Cuzick, J | 1 |
Al-Turki, HA; De Sutter, P; Devroey, P; Fatemi, HM; Kosmas, L; Papanikolaou, EG | 1 |
Conte, JV; Dropulic, LK; Girgis, R; Mcdyer, JF; Orens, JB; Shlobin, OA; Yang, SY | 1 |
Barfield, RC; Behm, FG; Burnette, K; Eldridge, P; Hale, GA; Handgretinger, R; Knapp, K | 1 |
Kamani, N; Panicker, J; Walsh, T | 1 |
Jarque, I; Salavert, M | 1 |
Buzdar, AU; Cuzick, J; Guastalla, JP; Nabholtz, JM | 1 |
Lee, GA; McDougall, R; Whitehead, K | 1 |
Arechavala, A; Bianchi, MH; López Daneri, G; Negroni, R; Robles, AM; Santiso, G | 1 |
Selleslag, D | 1 |
Chambers, D; Chin, W; Gabbay, E; Murray, R; Musk, M | 1 |
Dallot, A; Dannaoui, E; Dupont, B; Hot, A; Lortholary, O; Loulergue, P; Poirée, S | 1 |
Ampel, NM | 1 |
Sellart-Altisent, M; Torres-Rodríguez, JM | 1 |
Lin, NU; Winer, EP | 1 |
Catanzaro, A; Cloud, GA; Galgiani, JN; Holloway, M; Johnson, RH; Levine, BE; Lutz, JE; Mirels, LF; Rendon, A; Stevens, DA; Williams, PL | 1 |
Mian, P; Pagani, L; Spoladore, G; Vedovelli, C | 1 |
Abrams, JS; Cameron, DA; Castiglione, M; Davidson, NE; Goss, PE; Ingle, JN; Livingston, RB; Martino, S; Muss, HB; Norton, L; Palmer, MJ; Pater, JL; Perez, EA; Piccart, MJ; Pritchard, KI; Robert, NJ; Shepherd, LE; Tu, D | 1 |
Bahari, IS; Deris, ZZ; Harun, A; Ravichandran, M; Roziawati, Y; Shareef, BT | 1 |
Coleman, RL; Deavers, M; Gershenson, DM; Kavanagh, JJ; Levenback, C; Milam, MR; Ramirez, PT; Schmeler, KM; Slomovitz, BM; Smith, JA | 1 |
Nemeroff, CB | 1 |
Ecker, JA; Elie, R; Faludi, G; Fontaine, R; Kaplita, S; Kensler, TT; Ontiveros, A; Roberts, DL | 1 |
Marcus, RN; Mendels, J | 1 |
Montgomery, SA | 1 |
Abed, RT; Ascher, A; Baldwin, DS; Buckingham, SA; Cox, J; Hawley, CJ; Maragakis, BP; Pover, GH | 1 |
Brown, RE; Clark, M; Montgomery, SA | 1 |
Castañeda, R; Levy, R; Sussman, N; Westreich, LM | 1 |
Cartledge, JD; Clumeck, N; De Wit, S; Denning, DW; Dupont, B; Gazzard, BG; Hawkins, DA | 1 |
Bulun, SE; Carr, BR; Gunby, RT; Sasano, H; Takayama, K; Zeitoun, K | 1 |
Block, G; Cutler, N; Gross, M; Jiang, K; Reines, S; Smith, B; Teall, J; Tuchman, M; Willoughby, E | 1 |
Archibald, DG; Bielski, RJ; Bremner, J; Feiger, AD; Heiser, JF; Kaplita, SB; Kensler, TT; McQuade, RD; Roberts, DL; Trivedi, M; Wilcox, CS | 1 |
Deleu, D; Hanssens, Y | 1 |
El-Mallakh, RS | 1 |
Allen, C; Bomhof, M; Legg, N; Patel, K; Paz, J; Vandormael, K | 1 |
Logemann, CD; Rankin, LM | 1 |
Kranzler, HR; Modesto-Lowe, V; Van Kirk, J | 1 |
Ringdahl, EN | 1 |
Allen, C; Diener, HC; Pascual, J; Patel, K; Vega, P; Vrijens, F | 1 |
Saper, JR | 1 |
Potrebic, S; Raskin, NH | 1 |
Baker, SM; Trivedi, MH | 1 |
Borian, F; Ferguson, JM; Hartford, JT; Ieni, J; Jody, D; McQuade, RD; Shrivastava, RK; Stahl, SM | 1 |
Göbel, H; Heinze, A; Heinze-Kuhn, K; Lindner, V | 1 |
Dunner, DL | 1 |
Bauer, KS; Bostick-Bruton, F; Figg, WD; Fuse, E; Goldspiel, B; Kohn, EC; Kulpa, V; Liotta, LA; Minasian, L; Noone, M; Pluda, J; Reed, E; Sarosy, GA; Tompkins, A | 1 |
Baldwin, DS; Hawley, CJ; Mellors, K | 1 |
Keller, MB | 1 |
Ferrari, MD; Goadsby, PJ; Lipton, RB; Roon, KI | 1 |
Brink, S | 1 |
Barbosa, JS; Krymchantowski, AV | 1 |
Giaquinta, D; Horowitz, BJ; Ito, S | 1 |
Corson, SL; Kapikian, RR; Nehring, R | 1 |
Abendschein, DR; Bergmann, SR; Haskel, EJ; Torr, SR; VonVoigtlander, PF | 1 |
Bozzette, S; Chiu, J; Larsen, RA; Leal, MA; McCutchan, JA; Richman, DD | 1 |
Clumeck, N; De Wit, S; Goossens, H; Weerts, D | 1 |
Brammer, KW; Kutzer, E; Leodolter, S; Oittner, R | 1 |
Delecour, M | 1 |
26 review(s) available for triazoles and Recrudescence
Article | Year |
---|---|
Topics: Acetaminophen; Administration, Oral; Adolescent; Adsorption; Adult; Allyl Compounds; Amylopectin; Amylose; Anaerobiosis; Animals; Anti-Bacterial Agents; Anura; Arginase; Arthritis, Rheumatoid; Asthma; Atmosphere; B-Lymphocytes; Basic Helix-Loop-Helix Transcription Factors; Bioelectric Energy Sources; Biofilms; Biofuels; Biomarkers; Biopolymers; Bioreactors; Brain; Brain Injuries, Traumatic; Breast Neoplasms; Calibration; Carbon Tetrachloride; Caspase 3; Catalysis; Catechin; Cations; Cattle; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Body; Cell Line, Tumor; Cell Plasticity; Chemical and Drug Induced Liver Injury; Chemistry Techniques, Synthetic; China; Chitosan; Chloride Channels; Chromatography, High Pressure Liquid; Chromosome Mapping; Cognition; Cognitive Dysfunction; Cohort Studies; Colitis, Ulcerative; Colloids; Coloring Agents; Congresses as Topic; Correlation of Data; Crystallization; Cyanoacrylates; Cyclohexane Monoterpenes; Cyprinidae; Cytochrome P-450 CYP1A1; Death, Sudden; Dent Disease; Dietary Supplements; Diffusion Magnetic Resonance Imaging; Disease Models, Animal; Disease Progression; Disease Resistance; Disulfides; Drug Monitoring; Drug Stability; Ecotoxicology; Electricity; Electrodes; Endocytosis; Environmental Exposure; Environmental Monitoring; Enzyme Inhibitors; Epithelial-Mesenchymal Transition; Esophageal and Gastric Varices; Esters; Fagopyrum; Female; Ferrosoferric Oxide; Flame Retardants; Flavobacteriaceae; Flow Cytometry; Follow-Up Studies; Formoterol Fumarate; Fusarium; Garlic; Gastrointestinal Hemorrhage; Gene Expression; Genes, Plant; Genetic Markers; Glial Fibrillary Acidic Protein; Gliosis; Global Health; Glutathione Transferase; Glycine max; Gum Arabic; Hemostasis, Endoscopic; Hepatocytes; Hippocampus; Humans; Hydrogen-Ion Concentration; Illinois; Immunoglobulin G; Indoleamine-Pyrrole 2,3,-Dioxygenase; Infant, Newborn; Infant, Small for Gestational Age; Injections, Intraperitoneal; Interleukin-4; Iowa; Iron; Ki-67 Antigen; Kidney; Kinetics; Kynurenine; Lakes; Levofloxacin; Lipid Peroxidation; Lipids; Liver; Liver Cirrhosis, Experimental; Magnetic Fields; Magnetic Iron Oxide Nanoparticles; Male; Manure; Maze Learning; Memory, Short-Term; Metal Nanoparticles; Metals, Heavy; Methane; Mice; Mice, Inbred C57BL; Mice, Knockout; Michigan; Microalgae; Microbial Consortia; Mitochondria; Models, Animal; Models, Chemical; Models, Neurological; Molecular Structure; Molecular Weight; Mutation; Myeloid-Derived Suppressor Cells; NADPH Oxidase 2; Neoplasm Recurrence, Local; Neurites; Neurons; Neuroprotective Agents; NF-kappa B; NIH 3T3 Cells; Nitric Oxide Synthase Type II; Nitrogen; Ohio; Ointments; Ontario; Organelle Biogenesis; Organophosphates; Organophosphorus Compounds; Oxidative Stress; Palladium; Particle Size; Pectins; Phenotype; Phytotherapy; Piperidines; Placenta; Plant Diseases; Plant Extracts; Polymers; Polymorphism, Genetic; Polyphenols; Powders; Pregnancy; Pregnancy Trimester, First; Prospective Studies; Protein Kinase Inhibitors; Protein Structure, Secondary; Proteins; Pyridines; Pyrimidines; Rats, Wistar; Real-Time Polymerase Chain Reaction; Receptors, Aryl Hydrocarbon; Receptors, Chemokine; Receptors, Formyl Peptide; Receptors, Lipoxin; Recovery of Function; Recurrence; Reference Standards; Reference Values; Reproducibility of Results; Respiratory Function Tests; Retrospective Studies; Risk; Sensitivity and Specificity; Sewage; Signal Transduction; Sodium Glutamate; Soil; Solanum tuberosum; Solubility; Solutions; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis; Spermatozoa; STAT3 Transcription Factor; Sulfamethoxazole; Tea; Temperature; Thermodynamics; Thrombin; Treatment Outcome; Triazoles; United States; Viscosity; Waste Disposal, Fluid; Wastewater; Water; Water Pollutants, Chemical; Water Purification; White Matter; Wisconsin; X-Ray Diffraction; Zea mays | 2013 |
Midostaurin in acute myeloid leukemia: current evidence and practical considerations in routine clinical use.
Topics: Aniline Compounds; Anthracyclines; Antifungal Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cytarabine; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Echinocandins; fms-Like Tyrosine Kinase 3; Forecasting; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Maintenance Chemotherapy; Mutation; Mycoses; Protein Kinase Inhibitors; Pyrazines; Randomized Controlled Trials as Topic; Recurrence; Staurosporine; Triazoles | 2020 |
Risk for infections with selinexor in patients with relapsed/refractory multiple myeloma: a systematic review of clinical trials.
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Humans; Hydrazines; Infections; Multiple Myeloma; Recurrence; Triazoles | 2021 |
A meta-analysis of randomized controlled trials comparing the efficacy and safety of anastrozole versus tamoxifen for breast cancer.
Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Female; Humans; Nitriles; Randomized Controlled Trials as Topic; Recurrence; Survival Analysis; Tamoxifen; Treatment Outcome; Triazoles | 2017 |
The spectrum of pulmonary aspergillosis.
Topics: Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Aspergillus; Environmental Exposure; Fungi; Humans; Invasive Pulmonary Aspergillosis; Nitriles; Prognosis; Pulmonary Aspergillosis; Pyridines; Recurrence; Triazoles | 2018 |
[Invasive fungal rhinosinusitis in an apparently immunocompetant patient].
Topics: Aged; Antifungal Agents; Aortic Valve Stenosis; Aspergillosis; Chronic Disease; Female; Humans; Immunocompetence; Incidental Findings; Maxillary Sinusitis; Preoperative Care; Pyrimidines; Recurrence; Rhinitis; Triazoles; Voriconazole | 2013 |
The optimal duration and selection of adjuvant endocrine therapy for breast cancer: how long is enough?
Topics: Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Drug Administration Schedule; Female; Humans; Letrozole; Nitriles; Recurrence; Risk Factors; Tamoxifen; Time Factors; Triazoles | 2014 |
Exemestane as first-line therapy in postmenopausal women with recurrent or metastatic breast cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Celecoxib; Estrogens; Female; Humans; Letrozole; Middle Aged; Multicenter Studies as Topic; Neoplasms, Hormone-Dependent; Nitriles; Postmenopause; Pyrazoles; Randomized Controlled Trials as Topic; Recurrence; Salvage Therapy; Sulfonamides; Tamoxifen; Triazoles | 2010 |
Treatment of recurrent endometrial stromal sarcoma with letrozole: a case report and literature review.
Topics: Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Endometrial Neoplasms; Female; Humans; Letrozole; Middle Aged; Nitriles; Recurrence; Sarcoma, Endometrial Stromal; Triazoles | 2010 |
Soy products in the management of breast cancer.
Topics: Anastrozole; Animals; Aryl Hydrocarbon Hydroxylases; Asian People; Breast Neoplasms; Cytochrome P-450 CYP1B1; Diet; Drug Interactions; Female; Humans; Incidence; Isoflavones; Meta-Analysis as Topic; Nitriles; Polymorphism, Genetic; Prognosis; Proto-Oncogene Proteins c-mdm2; Receptor, ErbB-2; Recurrence; Risk Factors; Soy Foods; Tamoxifen; Triazoles | 2012 |
Evidence-based assessment of primary antifungal prophylaxis in patients with hematologic malignancies.
Topics: Adrenal Cortex Hormones; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Clinical Trials as Topic; Disease Susceptibility; Drug Carriers; Evidence-Based Medicine; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Liposomes; Mycoses; Neutropenia; Recurrence; Risk Factors; Triazoles | 2003 |
Rizatriptan: pharmacological differences from sumatriptan and clinical results.
Topics: Administration, Oral; Humans; Migraine Disorders; Patient Satisfaction; Recurrence; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines | 2001 |
Anastrozole.
Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Clinical Trials as Topic; Dose-Response Relationship, Drug; Female; Humans; Neoplasm Recurrence, Local; Nitriles; Postmenopause; Recurrence; Survival Rate; Tamoxifen; Triazoles | 2005 |
Successful treatment of disseminated scedosporium infection in 2 lung transplant recipients: review of the literature and recommendations for management.
Topics: Antifungal Agents; Blindness; Diagnosis, Differential; Drug Administration Schedule; Endophthalmitis; Humans; Kidney Pelvis; Lung Transplantation; Male; Middle Aged; Mycetoma; Polymerase Chain Reaction; Postoperative Complications; Pyrimidines; Recurrence; Retreatment; Scedosporium; Therapeutic Irrigation; Triazoles; Urine; Vision, Monocular; Voriconazole | 2006 |
Coccidioidomycosis in persons infected with HIV-1.
Topics: Amphotericin B; Antifungal Agents; CD4-Positive T-Lymphocytes; Coccidioidomycosis; HIV Infections; HIV-1; Humans; Patient Compliance; Recurrence; Triazoles | 2007 |
Evolutionary trends in the pharmacotherapeutic management of depression.
Topics: Adolescent; Adult; Age Factors; Aged; Animals; Antidepressive Agents; Antidepressive Agents, Tricyclic; Child; Clinical Trials as Topic; Cyclohexanols; Decision Trees; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Humans; Piperazines; Placebos; Recurrence; Selective Serotonin Reuptake Inhibitors; Trazodone; Triazoles; Venlafaxine Hydrochloride | 1994 |
Efficacy in long-term treatment of depression.
Topics: Amitriptyline; Antidepressive Agents; Antidepressive Agents, Second-Generation; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Humans; Imipramine; Long-Term Care; Piperazines; Placebos; Randomized Controlled Trials as Topic; Recurrence; Survival Rate; Treatment Outcome; Triazoles | 1996 |
Profiles of 5-HT 1B/1D agonists in acute migraine with special reference to second generation agents.
Topics: Acute Disease; Animals; Clinical Trials as Topic; Coronary Circulation; Coronary Vasospasm; Drug Design; Drug Interactions; Humans; Inactivation, Metabolic; Indoles; Meninges; Migraine Disorders; Molecular Structure; Nociceptors; Oxazoles; Oxazolidinones; Piperidines; Propranolol; Pyrrolidines; Randomized Controlled Trials as Topic; Rats; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Recurrence; Serotonin Receptor Agonists; Structure-Activity Relationship; Sumatriptan; Treatment Outcome; Triazoles; Tryptamines; Vasoconstrictor Agents | 1999 |
Newer intranasal migraine medications.
Topics: Administration, Intranasal; Administration, Oral; Analgesics, Non-Narcotic; Clinical Trials as Topic; Dihydroergotamine; Half-Life; Humans; Indoles; Migraine Disorders; Oxazoles; Oxazolidinones; Piperidines; Recurrence; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines | 2000 |
Treatment of recurrent vulvovaginal candidiasis.
Topics: Antifungal Agents; Boric Acids; Candidiasis, Vulvovaginal; Clotrimazole; Drug Interactions; Female; Fluconazole; Humans; Ketoconazole; Patient Education as Topic; Recurrence; Risk Factors; Teaching Materials; Time Factors; Triazoles | 2000 |
The use of rizatriptan in the treatment of acute, multiple migraine attacks.
Topics: Acute Disease; Humans; Migraine Disorders; Recurrence; Serotonin Receptor Agonists; Triazoles; Tryptamines | 2000 |
New abortive agents for the treatment of migraine.
Topics: Clinical Trials as Topic; Female; Humans; Indoles; Male; Migraine Disorders; Oxazolidinones; Piperidines; Prognosis; Recurrence; Serotonin Receptor Agonists; Severity of Illness Index; Sumatriptan; Treatment Outcome; Triazoles; Tryptamines | 2001 |
Clinical significance of monitoring early symptom change to predict outcome.
Topics: Algorithms; Citalopram; Clinical Trials as Topic; Depressive Disorder; Humans; Mental Disorders; Piperazines; Probability; Prognosis; Recurrence; Remission Induction; Severity of Illness Index; Terminology as Topic; Treatment Outcome; Triazoles | 2001 |
Acute and maintenance treatment of chronic depression.
Topics: Adult; Antidepressive Agents; Antidepressive Agents, Second-Generation; Chronic Disease; Cognitive Behavioral Therapy; Combined Modality Therapy; Depressive Disorder; Dysthymic Disorder; Humans; Multicenter Studies as Topic; Piperazines; Psychotherapy; Randomized Controlled Trials as Topic; Recurrence; Treatment Outcome; Triazoles | 2001 |
Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials.
Topics: Acute Disease; Administration, Oral; Humans; Indoles; Migraine Disorders; Pyrrolidines; Randomized Controlled Trials as Topic; Recurrence; Serotonin Receptor Agonists; Severity of Illness Index; Treatment Outcome; Triazoles; Tryptamines | 2001 |
Evolving pathogens in vulvovaginal candidiasis: implications for patient care.
Topics: Antifungal Agents; Candida; Candidiasis, Vulvovaginal; Female; Humans; Nonprescription Drugs; Ointments; Recurrence; Risk Factors; Species Specificity; Suppositories; Triazoles | 1992 |
36 trial(s) available for triazoles and Recrudescence
Article | Year |
---|---|
Topics: Acetaminophen; Administration, Oral; Adolescent; Adsorption; Adult; Allyl Compounds; Amylopectin; Amylose; Anaerobiosis; Animals; Anti-Bacterial Agents; Anura; Arginase; Arthritis, Rheumatoid; Asthma; Atmosphere; B-Lymphocytes; Basic Helix-Loop-Helix Transcription Factors; Bioelectric Energy Sources; Biofilms; Biofuels; Biomarkers; Biopolymers; Bioreactors; Brain; Brain Injuries, Traumatic; Breast Neoplasms; Calibration; Carbon Tetrachloride; Caspase 3; Catalysis; Catechin; Cations; Cattle; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Body; Cell Line, Tumor; Cell Plasticity; Chemical and Drug Induced Liver Injury; Chemistry Techniques, Synthetic; China; Chitosan; Chloride Channels; Chromatography, High Pressure Liquid; Chromosome Mapping; Cognition; Cognitive Dysfunction; Cohort Studies; Colitis, Ulcerative; Colloids; Coloring Agents; Congresses as Topic; Correlation of Data; Crystallization; Cyanoacrylates; Cyclohexane Monoterpenes; Cyprinidae; Cytochrome P-450 CYP1A1; Death, Sudden; Dent Disease; Dietary Supplements; Diffusion Magnetic Resonance Imaging; Disease Models, Animal; Disease Progression; Disease Resistance; Disulfides; Drug Monitoring; Drug Stability; Ecotoxicology; Electricity; Electrodes; Endocytosis; Environmental Exposure; Environmental Monitoring; Enzyme Inhibitors; Epithelial-Mesenchymal Transition; Esophageal and Gastric Varices; Esters; Fagopyrum; Female; Ferrosoferric Oxide; Flame Retardants; Flavobacteriaceae; Flow Cytometry; Follow-Up Studies; Formoterol Fumarate; Fusarium; Garlic; Gastrointestinal Hemorrhage; Gene Expression; Genes, Plant; Genetic Markers; Glial Fibrillary Acidic Protein; Gliosis; Global Health; Glutathione Transferase; Glycine max; Gum Arabic; Hemostasis, Endoscopic; Hepatocytes; Hippocampus; Humans; Hydrogen-Ion Concentration; Illinois; Immunoglobulin G; Indoleamine-Pyrrole 2,3,-Dioxygenase; Infant, Newborn; Infant, Small for Gestational Age; Injections, Intraperitoneal; Interleukin-4; Iowa; Iron; Ki-67 Antigen; Kidney; Kinetics; Kynurenine; Lakes; Levofloxacin; Lipid Peroxidation; Lipids; Liver; Liver Cirrhosis, Experimental; Magnetic Fields; Magnetic Iron Oxide Nanoparticles; Male; Manure; Maze Learning; Memory, Short-Term; Metal Nanoparticles; Metals, Heavy; Methane; Mice; Mice, Inbred C57BL; Mice, Knockout; Michigan; Microalgae; Microbial Consortia; Mitochondria; Models, Animal; Models, Chemical; Models, Neurological; Molecular Structure; Molecular Weight; Mutation; Myeloid-Derived Suppressor Cells; NADPH Oxidase 2; Neoplasm Recurrence, Local; Neurites; Neurons; Neuroprotective Agents; NF-kappa B; NIH 3T3 Cells; Nitric Oxide Synthase Type II; Nitrogen; Ohio; Ointments; Ontario; Organelle Biogenesis; Organophosphates; Organophosphorus Compounds; Oxidative Stress; Palladium; Particle Size; Pectins; Phenotype; Phytotherapy; Piperidines; Placenta; Plant Diseases; Plant Extracts; Polymers; Polymorphism, Genetic; Polyphenols; Powders; Pregnancy; Pregnancy Trimester, First; Prospective Studies; Protein Kinase Inhibitors; Protein Structure, Secondary; Proteins; Pyridines; Pyrimidines; Rats, Wistar; Real-Time Polymerase Chain Reaction; Receptors, Aryl Hydrocarbon; Receptors, Chemokine; Receptors, Formyl Peptide; Receptors, Lipoxin; Recovery of Function; Recurrence; Reference Standards; Reference Values; Reproducibility of Results; Respiratory Function Tests; Retrospective Studies; Risk; Sensitivity and Specificity; Sewage; Signal Transduction; Sodium Glutamate; Soil; Solanum tuberosum; Solubility; Solutions; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis; Spermatozoa; STAT3 Transcription Factor; Sulfamethoxazole; Tea; Temperature; Thermodynamics; Thrombin; Treatment Outcome; Triazoles; United States; Viscosity; Waste Disposal, Fluid; Wastewater; Water; Water Pollutants, Chemical; Water Purification; White Matter; Wisconsin; X-Ray Diffraction; Zea mays | 2013 |
A Phase II study of selinexor plus cytarabine and idarubicin in patients with relapsed/refractory acute myeloid leukaemia.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cytarabine; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Gastrointestinal Diseases; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Hydrazines; Idarubicin; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Male; Middle Aged; Progression-Free Survival; Recurrence; Salvage Therapy; Triazoles | 2020 |
Phase 1 study of selinexor plus carfilzomib and dexamethasone for the treatment of relapsed/refractory multiple myeloma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cytogenetic Analysis; Dexamethasone; Drug Resistance, Neoplasm; Female; Humans; Hydrazines; Male; Middle Aged; Multiple Myeloma; Neoplasm Staging; Oligopeptides; Prognosis; Recurrence; Retreatment; Treatment Outcome; Triazoles | 2019 |
A prospective phase II randomized study of deferasirox to prevent iatrogenic iron overload in patients undertaking induction/consolidation chemotherapy for acute myeloid leukaemia.
Topics: Adult; Aged; Benzoates; Consolidation Chemotherapy; Deferasirox; Early Termination of Clinical Trials; Female; Ferritins; Humans; Iatrogenic Disease; Induction Chemotherapy; Iron Chelating Agents; Iron Overload; Leukemia, Myeloid, Acute; Male; Middle Aged; Recurrence; Transfusion Reaction; Treatment Outcome; Triazoles; Young Adult | 2013 |
Efficacy and pharmacokinetic activity of frovatriptan compared to rizatriptan in patients with moderate-to-severe migraine.
Topics: Adult; Carbazoles; Cross-Over Studies; Double-Blind Method; Female; Half-Life; Humans; Male; Middle Aged; Migraine Disorders; Pilot Projects; Recurrence; Serotonin Receptor Agonists; Severity of Illness Index; Time Factors; Treatment Outcome; Triazoles; Tryptamines | 2014 |
Topics: Active Transport, Cell Nucleus; Adolescent; Adult; Aged; Aged, 80 and over; Atrial Natriuretic Factor; Benzhydryl Compounds; Benzylamines; Biopsy; Blood Glucose; Blood Transfusion; Cholesterol, LDL; Combined Modality Therapy; Cyclams; Diabetes Mellitus, Type 2; Disease Progression; Drug Administration Schedule; Enzyme-Linked Immunosorbent Assay; Female; Glucosides; Glycated Hemoglobin; Granulocyte Colony-Stimulating Factor; Hamstring Muscles; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Heterocyclic Compounds; Hodgkin Disease; Humans; Hydrazines; Immunohistochemistry; Insulin-Secreting Cells; Leg; Male; Middle Aged; Muscle Strength; Neoplasms; Peripheral Blood Stem Cell Transplantation; Range of Motion, Articular; Recurrence; Remission Induction; Research Design; Reverse Transcriptase Polymerase Chain Reaction; Soccer; Sodium-Glucose Transport Proteins; Sodium-Glucose Transporter 2 Inhibitors; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Triazoles; Young Adult | 2015 |
Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years.
Topics: Aged; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Disease-Free Survival; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Incidence; Kaplan-Meier Estimate; Letrozole; Middle Aged; Nitriles; Postmenopause; Quality of Life; Recurrence; Secondary Prevention; Triazoles | 2016 |
Select comorbid personality disorders and the treatment of chronic depression with nefazodone, targeted psychotherapy, or their combination.
Topics: Adaptation, Psychological; Adult; Antidepressive Agents, Second-Generation; Chronic Disease; Cognitive Behavioral Therapy; Combined Modality Therapy; Comorbidity; Culture; Depressive Disorder, Major; Dysthymic Disorder; Female; Humans; Male; Middle Aged; Personality Disorders; Personality Inventory; Piperazines; Problem Solving; Recurrence; Triazoles | 2009 |
Impact of body mass index on the efficacy of endocrine therapy in premenopausal patients with breast cancer: an analysis of the prospective ABCSG-12 trial.
Topics: Adult; Anastrozole; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Body Mass Index; Breast Neoplasms; Female; Goserelin; Humans; Middle Aged; Nitriles; Premenopause; Prospective Studies; Recurrence; Retrospective Studies; Risk; Tamoxifen; Treatment Outcome; Triazoles | 2011 |
FACT: an open-label randomized phase III study of fulvestrant and anastrozole in combination compared with anastrozole alone as first-line therapy for patients with receptor-positive postmenopausal breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Estradiol; Female; Fulvestrant; Humans; Middle Aged; Neoplasms, Hormone-Dependent; Nitriles; Receptors, Estrogen; Recurrence; Triazoles | 2012 |
Randomized, placebo-controlled trial of nefazodone maintenance treatment in preventing recurrence in chronic depression.
Topics: Acute Disease; Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Chronic Disease; Combined Modality Therapy; Cross-Over Studies; Depressive Disorder, Major; Double-Blind Method; Eligibility Determination; Female; Humans; Male; Middle Aged; Piperazines; Psychotherapy; Recurrence; Substance Withdrawal Syndrome; Triazoles | 2003 |
Therapeutic alliance in depression treatment: controlling for prior change and patient characteristics.
Topics: Adult; Antidepressive Agents, Second-Generation; Cognitive Behavioral Therapy; Combined Modality Therapy; Comorbidity; Depressive Disorder, Major; Dysthymic Disorder; Female; Humans; Male; Middle Aged; Outcome and Process Assessment, Health Care; Piperazines; Professional-Patient Relations; Recurrence; Triazoles | 2003 |
Rizatriptan 5 mg for the acute treatment of migraine in adolescents: results from a double-blind, single-attack study and two open-label, multiple-attack studies.
Topics: Acute Disease; Adolescent; Double-Blind Method; Female; Humans; Male; Migraine Disorders; Recurrence; Serotonin Receptor Agonists; Time Factors; Treatment Outcome; Triazoles; Tryptamines | 2004 |
Safety, tolerance, and efficacy of posaconazole therapy in patients with nonmeningeal disseminated or chronic pulmonary coccidioidomycosis.
Topics: Adult; Aged; Antifungal Agents; Coccidioidomycosis; Female; Humans; Lung Diseases, Fungal; Male; Middle Aged; Recurrence; Severity of Illness Index; Treatment Outcome; Triazoles | 2007 |
Intent-to-treat analysis of the placebo-controlled trial of letrozole for extended adjuvant therapy in early breast cancer: NCIC CTG MA.17.
Topics: Antineoplastic Agents; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Disease-Free Survival; Double-Blind Method; Estrogens; Humans; Kaplan-Meier Estimate; Letrozole; Lymphatic Metastasis; Neoplasms, Hormone-Dependent; Neoplasms, Second Primary; Nitriles; Patient Acceptance of Health Care; Placebos; Postmenopause; Progesterone; Proportional Hazards Models; Recurrence; Tamoxifen; Triazoles | 2008 |
Efficacy of letrozole in the treatment of recurrent platinum- and taxane-resistant high-grade cancer of the ovary or peritoneum.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Cisplatin; Disease Progression; Drug Resistance, Neoplasm; Female; Humans; Letrozole; Middle Aged; Nitriles; Ovarian Neoplasms; Peritoneal Neoplasms; Recurrence; Taxoids; Treatment Outcome; Triazoles | 2008 |
A double-blind comparison of nefazodone, imipramine, and placebo in major depression.
Topics: Adult; Aged; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Imipramine; Male; Middle Aged; Patient Compliance; Patient Dropouts; Piperazines; Placebos; Psychiatric Status Rating Scales; Recurrence; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome; Triazoles | 1994 |
Nefazodone in the treatment of severe, melancholic, and recurrent depression.
Topics: Adolescent; Adult; Age of Onset; Aged; Antidepressive Agents, Second-Generation; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Female; Humans; Imipramine; Male; Middle Aged; Personality Inventory; Piperazines; Placebos; Psychiatric Status Rating Scales; Recurrence; Severity of Illness Index; Treatment Outcome; Triazoles | 1996 |
A multicenter double-blind comparison of nefazodone and paroxetine in the treatment of outpatients with moderate-to-severe depression.
Topics: Adult; Aged; Ambulatory Care; Antidepressive Agents, Second-Generation; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Paroxetine; Piperazines; Psychiatric Status Rating Scales; Recurrence; Severity of Illness Index; Treatment Outcome; Triazoles | 1996 |
Economic analysis of treating depression with nefazodone v. imipramine.
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cost-Benefit Analysis; Depressive Disorder; Double-Blind Method; England; Humans; Imipramine; Models, Economic; Piperazines; Recurrence; Treatment Outcome; Triazoles; Wales | 1996 |
A dose comparison study of a new triazole antifungal (D0870) in HIV-positive patients with oral candidiasis.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Candida albicans; Candidiasis; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mouth Diseases; Recurrence; Treatment Outcome; Triazoles | 1997 |
Rizatriptan (MAXALT) for the acute treatment of migraine and migraine recurrence. A placebo-controlled, outpatient study. Rizatriptan 022 Study Group.
Topics: Acute Disease; Adolescent; Adult; Aged; Double-Blind Method; Female; Humans; Male; Middle Aged; Migraine Disorders; Recurrence; Serotonin Receptor Agonists; Triazoles; Tryptamines | 1998 |
Double-blind, placebo-substitution study of nefazodone in the prevention of relapse during continuation treatment of outpatients with major depression.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Outpatients; Piperazines; Recurrence; Triazoles | 1999 |
Rapid fade of antidepressant effect of nefazodone in bipolar depression.
Topics: Adult; Antidepressive Agents, Second-Generation; Bipolar Disorder; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Piperazines; Placebo Effect; Recurrence; Research Design; Treatment Failure; Treatment Outcome; Triazoles | 1999 |
Comparison of rizatriptan 10 mg vs. naratriptan 2.5 mg in migraine.
Topics: Adult; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Indoles; Male; Middle Aged; Migraine Disorders; Piperidines; Recurrence; Serotonin Receptor Agonists; Treatment Outcome; Triazoles; Tryptamines | 1999 |
Naltrexone vs. nefazodone for treatment of alcohol dependence. A placebo-controlled trial.
Topics: Adult; Alcoholism; Antidepressive Agents, Second-Generation; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Naltrexone; Narcotic Antagonists; Patient Compliance; Piperazines; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Recurrence; Selective Serotonin Reuptake Inhibitors; Time Factors; Triazoles | 2000 |
Comparison of rizatriptan 10 mg vs. zolmitriptan 2.5 mg in the acute treatment of migraine. Rizatriptan-Zolmitriptan Study Group.
Topics: Adult; Disability Evaluation; Double-Blind Method; Female; Humans; Male; Migraine Disorders; Oxazolidinones; Quality of Life; Recurrence; Retreatment; Serotonin Receptor Agonists; Time Factors; Triazoles; Tryptamines | 2000 |
Reemergence of sexual dysfunction in patients with major depressive disorder: double-blind comparison of nefazodone and sertraline.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Depressive Disorder; Double-Blind Method; Female; Humans; Incidence; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Recurrence; Sertraline; Sexual Dysfunctions, Psychological; Treatment Outcome; Triazoles | 2001 |
Efficacy and tolerability of rizatriptan 10 mg in migraine: experience with 70 527 patient episodes.
Topics: Adult; Female; Humans; Male; Migraine Disorders; Recurrence; Serotonin Receptor Agonists; Time Factors; Treatment Outcome; Triazoles; Tryptamines | 2001 |
A phase I trial of carboxyamido-triazole and paclitaxel for relapsed solid tumors: potential efficacy of the combination and demonstration of pharmacokinetic interaction.
Topics: Adult; Aged; Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relationship, Drug; Drug Interactions; Female; Humans; Inhibitory Concentration 50; Male; Mice; Mice, Nude; Middle Aged; Neoplasms; Neovascularization, Pathologic; Ovarian Neoplasms; Paclitaxel; Recurrence; Time Factors; Treatment Outcome; Triazoles; Tumor Cells, Cultured | 2001 |
A randomized, double-blind controlled comparison of nefazodone and paroxetine in the treatment of depression: safety, tolerability and efficacy in continuation phase treatment.
Topics: Adult; Aged; Bipolar Disorder; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Long-Term Care; Male; Middle Aged; Paroxetine; Piperazines; Psychiatric Status Rating Scales; Recurrence; Treatment Outcome; Triazoles | 2001 |
Rizatriptan combined with rofecoxib vs. rizatriptan for the acute treatment of migraine: an open label pilot study.
Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase Inhibitors; Drug Therapy, Combination; Female; Humans; Lactones; Male; Middle Aged; Migraine Disorders; Nausea; Pilot Projects; Prospective Studies; Recurrence; Serotonin Receptor Agonists; Sulfones; Triazoles; Tryptamines | 2002 |
Terconazole and miconazole cream for treating vulvovaginal candidiasis. A comparison.
Topics: Administration, Intravaginal; Adolescent; Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Double-Blind Method; Female; Humans; Miconazole; Middle Aged; Recurrence; Triazoles | 1991 |
Comparison of fluconazole and ketoconazole for oropharyngeal candidiasis in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Aged; AIDS-Related Complex; Candidiasis, Oral; Clinical Trials as Topic; Double-Blind Method; Female; Fluconazole; Follow-Up Studies; Humans; Ketoconazole; Male; Middle Aged; Oropharynx; Pharyngeal Diseases; Prospective Studies; Recurrence; Triazoles | 1989 |
A comparison of fluconazole and ketoconazole in the oral treatment of vaginal candidiasis; report of a double-blind multicentre trial.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antifungal Agents; Candidiasis, Vulvovaginal; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation; Female; Fluconazole; Humans; Ketoconazole; Middle Aged; Multicenter Studies as Topic; Random Allocation; Recurrence; Triazoles | 1988 |
Advantages of a 6- to 7-day treatment with 40-mg vaginal suppositories of terconazole against vaginal candidosis: conclusions drawn from a phase II multicentre study in France.
Topics: Adolescent; Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Clinical Trials as Topic; Female; Humans; Recurrence; Suppositories; Time Factors; Triazoles; Vagina | 1985 |
75 other study(ies) available for triazoles and Recrudescence
Article | Year |
---|---|
[New European approval: Selinexor for triple class refractory multiple myeloma].
Topics: Administration, Oral; ADP-ribosyl Cyclase 1; Antibodies, Monoclonal, Humanized; Clinical Trials, Phase II as Topic; Drug Resistance, Neoplasm; Europe; Humans; Hydrazines; Immunomodulating Agents; Membrane Glycoproteins; Multiple Myeloma; Proteasome Inhibitors; Recurrence; Triazoles | 2022 |
Successful Treatment of Recurrent Cutaneous Purpureocillium lilacinum (Paecilomyces lilacinus) Infection with Posaconazole and Surgical Debridement.
Topics: Administration, Cutaneous; Adult; Anemia, Hemolytic, Autoimmune; Antifungal Agents; Combined Modality Therapy; Debridement; Dermatomycoses; Follow-Up Studies; Humans; Immunocompromised Host; Male; Paecilomyces; Recurrence; Risk Assessment; Severity of Illness Index; Thrombocytopenia; Treatment Outcome; Triazoles | 2019 |
Disseminated Lomentospora prolificans infection in a patient on idelalisib-rituximab therapy for relapsed chronic lymphocytic leukaemia.
Topics: Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Drug Resistance, Multiple, Fungal; Drug Substitution; Fatal Outcome; Febrile Neutropenia; Female; Filgrastim; Fluconazole; Humans; Immunocompromised Host; Invasive Fungal Infections; Leukemia, Lymphocytic, Chronic, B-Cell; Middle Aged; Piperacillin, Tazobactam Drug Combination; Purines; Quinazolinones; Recurrence; Rituximab; Scedosporium; Triazoles; Valacyclovir; Vidarabine | 2020 |
Safety, Tolerability, and Efficacy of Selinexor in a Patient With Relapsed Light Chain (AL) Amyloidosis.
Topics: Humans; Hydrazines; Immunoglobulin Light-chain Amyloidosis; Male; Middle Aged; Recurrence; Triazoles | 2021 |
The role of hormonal therapy in patients with relapsed high-grade ovarian carcinoma: a retrospective series of tamoxifen and letrozole.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Carcinoma; Female; Humans; Letrozole; Middle Aged; Neoplasm Grading; Neoplasm Staging; Nitriles; Ovarian Neoplasms; Receptors, Estrogen; Recurrence; Retreatment; Retrospective Studies; Tamoxifen; Treatment Outcome; Triazoles; Young Adult | 2017 |
In vitro activity of isavuconazole against fluconazole-resistant isolates of Histoplasma capsulatum.
Topics: Antifungal Agents; Drug Resistance, Fungal; Fluconazole; Histoplasma; Histoplasmosis; Humans; Microbial Sensitivity Tests; Nitriles; Pyridines; Recurrence; Triazoles | 2018 |
Positioning biologics-A case-based discussion: Surgery and clinical trials.
Topics: Administration, Oral; Adult; Antibodies, Monoclonal, Humanized; Biosimilar Pharmaceuticals; Combined Modality Therapy; Crohn Disease; Digestive System Surgical Procedures; Female; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Male; Pregnancy; Pregnancy, High-Risk; Pyridines; Randomized Controlled Trials as Topic; Recurrence; Severity of Illness Index; Triazoles; Ustekinumab; Young Adult | 2018 |
Treatment of Suspected Invasive Fungal Infection in War Wounds.
Topics: Administration, Topical; Afghan Campaign 2001-; Amphotericin B; Antifungal Agents; beta-Cyclodextrins; Debridement; Excipients; Humans; Mycoses; Recurrence; Risk Factors; Tobramycin; Treatment Outcome; Triazoles; Vancomycin; Voriconazole; Wounds and Injuries | 2018 |
Posaconazole in the treatment of refractory
Topics: Administration, Oral; Adult; Antifungal Agents; Diagnosis, Differential; Eye Infections, Fungal; Female; Humans; Keratitis; Keratoplasty, Penetrating; Paecilomyces; Recurrence; Triazoles | 2019 |
The incidence of invasive fungal infections in neutropenic patients with acute leukemia and myelodysplastic syndromes receiving primary antifungal prophylaxis with voriconazole.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillus; Female; Humans; Incidence; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Myelodysplastic Syndromes; Neutropenia; Pyrimidines; Recurrence; Remission Induction; Retrospective Studies; Rhizopus; Triazoles; Voriconazole | 2013 |
Lobomycosis successfully treated with posaconazole.
Topics: Adult; Chronic Disease; Follow-Up Studies; Humans; Lacazia; Lobomycosis; Male; Peru; Recurrence; Treatment Outcome; Triazoles | 2013 |
Relapse of fungal meningitis associated with contaminated methylprednisolone.
Topics: Aged, 80 and over; Antifungal Agents; Drug Administration Schedule; Drug Contamination; Humans; Injections, Epidural; Male; Meningitis, Fungal; Methylprednisolone; Methylprednisolone Acetate; Pyrimidines; Recurrence; Saccharomycetales; Triazoles; Voriconazole | 2013 |
Management of prepubertal gynecomastia in two monozygotic twins with Peutz-Jeghers syndrome: from aromatase inhibitors to subcutaneous mastectomy.
Topics: Adrenal Glands; Anastrozole; Aromatase Inhibitors; Child; Combined Modality Therapy; Comorbidity; Diseases in Twins; Gynecomastia; Humans; Lithiasis; Male; Mastectomy, Subcutaneous; Nitriles; Peutz-Jeghers Syndrome; Recurrence; Testicular Diseases; Testis; Triazoles; Ultrasonography, Mammary | 2013 |
Invasive mucormycosis without radiological alterations.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Female; Fungi; Humans; Liposomes; Mucormycosis; Neutropenia; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Remission Induction; Stem Cell Transplantation; Tomography, X-Ray Computed; Triazoles | 2013 |
Scedosporium prolificans fungaemia in a patient with acute lymphoblastic leukaemia.
Topics: Allografts; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Drug Substitution; Fatal Outcome; Female; Fluconazole; Fungemia; Graft vs Host Disease; Humans; Immunocompromised Host; Immunosuppressive Agents; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Scedosporium; Triazoles; Voriconazole; Young Adult | 2013 |
Efinaconazole solution 10%: topical antifungal therapy for toenail onychomycosis.
Topics: Administration, Topical; Antifungal Agents; Foot Dermatoses; Humans; Onychomycosis; Recurrence; Triazoles | 2013 |
Recurrent erythematous plaques on sun-exposed sites in an African American boy with chronic granulomatous disease.
Topics: Biopsy, Needle; Child; Granulomatous Disease, Chronic; Humans; Immunocompromised Host; Immunohistochemistry; Lung Diseases, Fungal; Lupus Erythematosus, Discoid; Male; Photosensitivity Disorders; Prognosis; Pyrimidines; Recurrence; Severity of Illness Index; Sunlight; Triazoles; Voriconazole | 2014 |
Recurrence of chronic pulmonary aspergillosis after discontinuation of maintenance treatment by antifungal triazoles.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Female; Humans; Maintenance Chemotherapy; Male; Middle Aged; Pulmonary Aspergillosis; Recurrence; Retrospective Studies; Risk Factors; Substance Withdrawal Syndrome; Triazoles | 2014 |
Antitrypanosomal Treatment with Benznidazole Is Superior to Posaconazole Regimens in Mouse Models of Chagas Disease.
Topics: 14-alpha Demethylase Inhibitors; Administration, Oral; Animals; Chagas Disease; Clinical Trials, Phase II as Topic; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Heart; Humans; Immunosuppression Therapy; Mice; NIH 3T3 Cells; Nitroimidazoles; Parasitemia; Recurrence; Sterol 14-Demethylase; Triazoles; Trypanocidal Agents; Trypanosoma cruzi | 2015 |
Onychomycosis: Strategies to Minimize Recurrence.
Topics: Administration, Topical; Antifungal Agents; Comorbidity; Diabetes Mellitus; Drug Administration Schedule; Humans; Itraconazole; Morpholines; Naphthalenes; Onychomycosis; Prevalence; Recurrence; Terbinafine; Tinea Pedis; Triazoles | 2016 |
Recurrent trichosporonosis with central nervous system involvement in an allogeneic hematopoietic stem cell transplant recipient.
Topics: Anemia, Aplastic; Antibiotic Prophylaxis; Antifungal Agents; Caspofungin; Central Nervous System; Echinocandins; Female; Hematopoietic Stem Cell Transplantation; Humans; Hydrocephalus; Immunocompromised Host; Immunosuppression Therapy; Laminectomy; Lipopeptides; Magnetic Resonance Imaging; Opportunistic Infections; Recurrence; Transplantation, Autologous; Treatment Outcome; Triazoles; Trichosporon; Trichosporonosis; Ventriculoperitoneal Shunt; Voriconazole | 2016 |
Tinea and Onychomycosis.
Topics: Administration, Cutaneous; Antifungal Agents; Humans; Imidazoles; Onychomycosis; Recurrence; Tinea; Tinea Pedis; Triazoles | 2016 |
Breakthrough disseminated Scedosporium prolificans infection in a patient with relapsed leukaemia on prolonged voriconazole followed by posaconazole prophylaxis.
Topics: Administration, Oral; Antifungal Agents; Antineoplastic Agents; Fatal Outcome; Humans; Leukemia; Male; Middle Aged; Mycetoma; Opportunistic Infections; Pyrimidines; Recurrence; Scedosporium; Triazoles; Voriconazole | 2008 |
Emergence of resistance to amphotericin B and triazoles in Candida glabrata vaginal isolates in a case of recurrent vaginitis.
Topics: Amphotericin B; Antifungal Agents; Candida glabrata; DNA Fingerprinting; DNA, Fungal; Drug Resistance, Fungal; Female; Humans; Recurrence; Sequence Analysis, DNA; Triazoles; Vaginitis | 2008 |
Immune reconstitution syndrome after voriconazole treatment for cryptococcal meningitis in a liver transplant recipient.
Topics: Adrenal Cortex Hormones; Anti-Retroviral Agents; Antifungal Agents; Female; HIV Infections; Humans; Immune Reconstitution Inflammatory Syndrome; Immune System; Inflammation; Liver Transplantation; Magnetic Resonance Imaging; Meningitis, Cryptococcal; Middle Aged; Pyrimidines; Recurrence; Triazoles; Voriconazole | 2008 |
[A new pharmacological treatment option for alcohol dependence discovered in transnational study: neurokinin-1 receptor antagonist as a possible therapy for alcoholism?].
Topics: Adult; Alcohol Deterrents; Alcoholism; Animals; Double-Blind Method; Female; Humans; Male; Mice; Mice, Knockout; Middle Aged; Neurokinin-1 Receptor Antagonists; Pyridines; Randomized Controlled Trials as Topic; Receptors, Neurokinin-1; Recurrence; Research; Substance P; Triazoles; Young Adult | 2008 |
[Cryptococcal meningoencephalitis related to HIV infection with resistance to fluconazole, relapse, and IRIS].
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antifungal Agents; Cryptococcus neoformans; Drug Resistance, Fungal; Drug Therapy, Combination; Fluconazole; HIV Seropositivity; Humans; Male; Meningitis, Cryptococcal; Pyrimidines; Recurrence; Triazoles; Voriconazole | 2009 |
Posaconazole-increased vincristine neurotoxicity in a child: a case report.
Topics: Antifungal Agents; Antineoplastic Agents, Phytogenic; Child; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Female; Humans; Mycoses; Nervous System Diseases; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Triazoles; Vincristine | 2009 |
Successful salvage treatment of Scedosporium apiospermum keratitis with topical voriconazole after failure of natamycin.
Topics: Administration, Topical; Antifungal Agents; Cost-Benefit Analysis; Eye Infections, Fungal; Female; Humans; Keratitis; Microbial Sensitivity Tests; Middle Aged; Natamycin; Pyrimidines; Recurrence; Salvage Therapy; Scedosporium; Triazoles; Visual Acuity; Voriconazole | 2009 |
[Nineteen years postoperatively, anastrozole, UFT and cyclophosphamide combination therapy remained effective against recurrent hormone responsive breast cancer with intraabdominal lymphnode, pleural, skin and bone metastases in old age following sixteen-
Topics: Aged, 80 and over; Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Female; Hormone Replacement Therapy; Humans; Lymphatic Metastasis; Nitriles; Pleural Neoplasms; Radiography; Recurrence; Skin Neoplasms; Tamoxifen; Tegafur; Time Factors; Triazoles; Uracil | 2009 |
Preservation of fertility in patients with cancer.
Topics: Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Fertility; Humans; Letrozole; Neoplasms; Nitriles; Ovary; Ovulation Induction; Recurrence; Time Factors; Triazoles | 2009 |
Trends in frequency and in vitro antifungal susceptibility patterns of Candida isolates from women attending the STD outpatients clinic of a tertiary care hospital in Northern Italy during the years 2002-2007.
Topics: Antifungal Agents; Candida; Candidiasis, Vulvovaginal; Drug Resistance, Fungal; Female; Fluconazole; Humans; Italy; Microbial Sensitivity Tests; Outpatient Clinics, Hospital; Prevalence; Pyrimidines; Recurrence; Triazoles; Vagina; Voriconazole | 2009 |
Aromatase inhibitor for treatment of a recurrent abdominal wall endometrioma in a postmenopausal woman.
Topics: Abdominal Wall; Aromatase Inhibitors; Endometriosis; Female; Humans; Letrozole; Middle Aged; Nitriles; Postmenopause; Recurrence; Thoracic Diseases; Treatment Outcome; Triazoles | 2009 |
Treatment of autonomous ovarian follicular cyst with long-term anastrozole therapy.
Topics: Anastrozole; Aromatase Inhibitors; Child; Female; Humans; Nitriles; Ovarian Cysts; Puberty, Precocious; Recurrence; Triazoles | 2009 |
Chronic necrotizing and allergic bronchopulmonary aspergillosis in an asthmatic patient--a therapeutic challenge.
Topics: Administration, Inhalation; Adrenal Cortex Hormones; Adult; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Aspergillus fumigatus; Asthma; Bronchoscopy; Caspofungin; Chronic Disease; Drug Therapy, Combination; Echinocandins; Female; Humans; Invasive Pulmonary Aspergillosis; Lipopeptides; Prognosis; Pyrimidines; Radiography, Thoracic; Recurrence; Risk Assessment; Severity of Illness Index; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole | 2008 |
Isolation of Exophiala dermatitidis from pigmented sputum in a cystic fibrosis patient.
Topics: Adolescent; Adrenal Cortex Hormones; Antifungal Agents; Cystic Fibrosis; Exophiala; Female; Humans; Lung Diseases, Fungal; Mycoses; Pyrimidines; Recurrence; Sputum; Triazoles; Voriconazole | 2010 |
Mucormycosis may mimic disease relapse in Wegener's granulomatosis.
Topics: Adult; Amphotericin B; Antifungal Agents; Diagnosis, Differential; Drug Therapy, Combination; Granulomatosis with Polyangiitis; Humans; Immunocompromised Host; Male; Mucormycosis; Radiography, Thoracic; Recurrence; Treatment Outcome; Triazoles | 2010 |
[Rebound after ABPA treatment with voriconazole].
Topics: Adult; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Female; Humans; Male; Middle Aged; Pyrimidines; Recurrence; Triazoles; Voriconazole | 2010 |
Resolution of recurrent fusarium arthritis after prolonged antifungal therapy.
Topics: Ankle Joint; Antifungal Agents; Arthritis, Infectious; Drug Therapy, Combination; Fusarium; Humans; Immunocompromised Host; Mycoses; Pyrimidines; Recurrence; Toe Joint; Triazoles; Voriconazole | 2011 |
Recurrent Lecythophora mutabilis keratitis and endophthalmitis after deep anterior lamellar keratoplasty.
Topics: Amphotericin B; Antifungal Agents; Combined Modality Therapy; Corneal Transplantation; Corneal Ulcer; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Fungal; Female; Humans; Microscopy, Acoustic; Middle Aged; Mycoses; Phialophora; Pyrimidines; Recurrence; Triazoles; Voriconazole | 2011 |
Association between breast cancer subtypes and response to neoadjuvant anastrozole.
Topics: Anastrozole; Aromatase Inhibitors; Breast Neoplasms; Female; Gene Expression Regulation, Neoplastic; Humans; Ki-67 Antigen; Neoadjuvant Therapy; Neoplasm Staging; Neoplasms, Hormone-Dependent; Nitriles; Oligonucleotide Array Sequence Analysis; Postmenopause; Receptor, ErbB-2; Receptors, Estrogen; Recurrence; Treatment Outcome; Triazoles | 2011 |
An in vitro model showing adaptation to long-term oestrogen deprivation highlights the clinical potential for targeting kinase pathways in combination with aromatase inhibition.
Topics: Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Aromatase Inhibitors; Breast Neoplasms; Cell Line, Tumor; Drug Resistance, Neoplasm; Estradiol; Estrogens; Female; Fulvestrant; Gene Expression Profiling; Humans; Insulin-Like Growth Factor I; Models, Biological; Nitriles; Postmenopause; Receptors, Estrogen; Recurrence; Triazoles | 2011 |
Delayed recalcitrant fungal endophthalmitis secondary to Curvularia.
Topics: Abscess; Aged; Amphotericin B; Ascomycota; Cataract Extraction; Combined Modality Therapy; Drug Therapy, Combination; Endophthalmitis; Eye Enucleation; Eye Infections, Fungal; Female; Humans; Mycoses; Pyrimidines; Recurrence; Triazoles; Vitrectomy; Vitreous Body; Voriconazole | 2011 |
Recurrent Saccharomyces cerevisiae fungemia in an otherwise healthy patient.
Topics: Abdominal Pain; Adult; Amphotericin B; Antifungal Agents; Chills; Diagnosis, Differential; Female; Fever; Fluconazole; Flucytosine; Fungemia; Headache; Humans; Nausea; Pyrimidines; Recurrence; Saccharomyces cerevisiae; Triazoles; Voriconazole | 2011 |
[A case of recurrent breast cancer with brain metastases successfully treated with vinorelbine and anastrozole after multiple chemo-endocrine therapies].
Topics: Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Breast Neoplasms; Female; Humans; Middle Aged; Nitriles; Receptors, Estrogen; Recurrence; Triazoles; Vinblastine; Vinorelbine | 2012 |
Recurrent fungal iris granuloma in a 10-year-old child.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Child; Drug Therapy, Combination; Eye Infections, Fungal; Female; Fluconazole; Granuloma; Humans; Iris Diseases; Pyrimidines; Recurrence; Treatment Outcome; Triazoles; Voriconazole | 2012 |
Refractory disseminated fusariosis by Fusarium verticillioides in a patient with acute myeloid leukaemia relapsed after allogeneic hematopoietic stem cell transplantation: a case report and literature review.
Topics: Adult; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cytarabine; Drug Resistance, Multiple, Fungal; Etoposide; Fatal Outcome; Female; Fusariosis; Fusarium; Humans; Immunocompromised Host; Itraconazole; Leukemia, Myeloid, Acute; Mitoxantrone; Neutropenia; Peripheral Blood Stem Cell Transplantation; Postoperative Complications; Premedication; Pyrimidines; Recurrence; Salvage Therapy; Transplantation, Homologous; Triazoles; Voriconazole | 2013 |
[Efficacy of voriconazole treatment in chronic vulvovaginal candidosis due to Candida glabrata].
Topics: Adult; Antifungal Agents; Candida glabrata; Candidiasis, Vulvovaginal; Cesarean Section; Drug Evaluation; Drug Resistance, Multiple, Fungal; Female; Fluconazole; Humans; Microbial Sensitivity Tests; Pregnancy; Puerperal Disorders; Pyrimidines; Recurrence; Species Specificity; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2013 |
Management of recurrent Paecilomyces lilacinus keratitis.
Topics: Aged; Humans; Keratitis; Male; Mycoses; Paecilomyces; Pyrimidines; Recurrence; Triazoles; Voriconazole | 2013 |
Breakthrough pulmonary Aspergillus fumigatus infection with multiple triazole resistance in a Spanish patient with chronic myeloid leukemia.
Topics: Adult; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillus fumigatus; Caspofungin; Combined Modality Therapy; Cytochrome P-450 Enzyme System; Drug Resistance, Multiple, Fungal; Echinocandins; Fatal Outcome; Female; Fungal Proteins; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lipopeptides; Point Mutation; Postoperative Complications; Pulmonary Aspergillosis; Recurrence; Spain; Species Specificity; Transplantation Conditioning; Transplantation, Homologous; Triazoles | 2013 |
Relapsing cerebral aspergilloma associated with pregnancy.
Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Brain; Central Nervous System Fungal Infections; Female; Humans; Infant, Newborn; Magnetic Resonance Imaging; Pregnancy; Pregnancy Complications, Infectious; Pyrimidines; Recurrence; Seizures; Triazoles; Voriconazole | 2013 |
[Acute liver failure in nefazodone therapy? A case report].
Topics: Antidepressive Agents; Chemical and Drug Induced Liver Injury; Depressive Disorder; Fatal Outcome; Humans; Liver Failure, Acute; Liver Function Tests; Liver Transplantation; Male; Middle Aged; Piperazines; Recurrence; Triazoles | 2002 |
Voriconazole in the management of invasive aspergillosis in two patients with acute myeloid leukemia undergoing stem cell transplantation.
Topics: Adult; Amphotericin B; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Bone Marrow Transplantation; Combined Modality Therapy; Cytarabine; Daunorubicin; Deoxycholic Acid; Drug Combinations; Drug Resistance, Fungal; Etoposide; Fatal Outcome; Humans; Immunocompromised Host; Itraconazole; Leukemia, Megakaryoblastic, Acute; Leukemia, Myelomonocytic, Acute; Liposomes; Lung Diseases, Fungal; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Pyrimidines; Recurrence; Remission Induction; Salvage Therapy; Transplantation Conditioning; Transplantation, Autologous; Transplantation, Homologous; Triazoles; Voriconazole | 2002 |
Secondary antifungal prophylaxis with voriconazole to adhere to scheduled treatment in leukemic patients and stem cell transplant recipients.
Topics: Adolescent; Adult; Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Female; Graft vs Host Disease; Humans; Leukemia; Male; Middle Aged; Prognosis; Prospective Studies; Pyrimidines; Recurrence; Risk; Stem Cell Transplantation; Transplantation, Homologous; Triazoles; Voriconazole | 2004 |
Triptans for migraine therapy: a comparison based on number needed to treat and doses needed to treat.
Topics: Algorithms; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Costs; Humans; Managed Care Programs; Migraine Disorders; Piperidines; Pyrrolidines; Recurrence; Serotonin Receptor Agonists; Time Factors; Treatment Outcome; Triazoles; Tryptamines | 2005 |
Successful treatment of an aggressive recurrent post-menopausal endometriosis with an aromatase inhibitor.
Topics: Aromatase Inhibitors; Colon, Sigmoid; Endometriosis; Female; Humans; Hysterectomy; Letrozole; Middle Aged; Nitriles; Postmenopause; Recurrence; Sciatica; Time Factors; Treatment Outcome; Triazoles | 2005 |
Mediastinal mass due to Aspergillus fumigatus after lung transplantation: a case report.
Topics: Adult; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Caspofungin; Cystic Fibrosis; Drug Therapy, Combination; Echinocandins; Fatal Outcome; Female; Humans; Immunocompromised Host; Lipopeptides; Lung Transplantation; Magnetic Resonance Imaging; Mediastinal Diseases; Peptides, Cyclic; Postoperative Complications; Pyrimidines; Recurrence; Thoracoscopy; Triazoles; Voriconazole | 2005 |
Autologous transplantation of CD133 selected hematopoietic progenitor cells for treatment of relapsed acute lymphoblastic leukemia.
Topics: AC133 Antigen; Amphotericin B; Antifungal Agents; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Caspofungin; Child; Combined Modality Therapy; Contraindications; Dexamethasone; Drug Therapy, Combination; Echinocandins; Glycoproteins; Humans; Immunomagnetic Separation; Lipopeptides; Male; Mercaptopurine; Methotrexate; Peptides; Peptides, Cyclic; Peripheral Blood Stem Cell Transplantation; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Recurrence; Remission Induction; Salvage Therapy; Transplantation, Autologous; Transplantation, Homologous; Triazoles; Vincristine; Voriconazole; Zygomycosis | 2007 |
Recurrent central nervous system blastomycosis in an immunocompetent child treated successfully with sequential liposomal amphotericin B and voriconazole.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Blastomyces; Blastomycosis; Central Nervous System Fungal Infections; Drug Administration Schedule; Humans; Immunocompetence; Male; Pyrimidines; Recurrence; Treatment Outcome; Triazoles; Voriconazole | 2006 |
[Effect of new antifungals on the etiology of invasive fungal infections: emergence, resistance and breakthrough infection].
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Communicable Diseases, Emerging; Drug Resistance, Multiple, Fungal; Humans; Immunocompromised Host; Mycoses; Organ Transplantation; Postoperative Complications; Prosthesis-Related Infections; Pyrimidines; Recurrence; Triazoles; Voriconazole; Zygomycosis | 2006 |
Impact of chemotherapy regimens prior to endocrine therapy: Results from the ATAC (Anastrozole and Tamoxifen, Alone or in Combination) trial.
Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Humans; Middle Aged; Nitriles; Randomized Controlled Trials as Topic; Recurrence; Retrospective Studies; Tamoxifen; Treatment Outcome; Triazoles | 2006 |
Management of paecilomyces keratitis.
Topics: Adult; Antifungal Agents; Corneal Transplantation; Eye Infections, Fungal; Female; Humans; Keratitis; Paecilomyces; Pyrimidines; Recurrence; Sclera; Treatment Outcome; Triazoles; Voriconazole | 2007 |
[Clinical cases in medical mycology. Case no. 21].
Topics: Amphotericin B; Antifungal Agents; Dermatomycoses; Drug Resistance, Fungal; Endophthalmitis; Exophiala; Female; Fungemia; Humans; Itraconazole; Middle Aged; Mycoses; Opportunistic Infections; Osteolysis; Pregnancy; Pregnancy Complications, Infectious; Pyrimidines; Recurrence; Th2 Cells; Triazoles; Voriconazole | 2006 |
A case of fusariosis in an immunocompromised patient successfully treated with liposomal amphotericin B.
Topics: Abscess; Amphotericin B; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Combined Modality Therapy; Cytarabine; Foot Dermatoses; Fusarium; Humans; Imatinib Mesylate; Immunocompromised Host; Liposomes; Male; Middle Aged; Muscular Diseases; Onychomycosis; Peripheral Blood Stem Cell Transplantation; Piperazines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Recurrence; Remission Induction; Reoperation; Rituximab; Teniposide; Triazoles; Voriconazole | 2006 |
Successful treatment of black-grain mycetoma with voriconazole.
Topics: Antifungal Agents; Humans; Madurella; Male; Middle Aged; Mycetoma; Pyrimidines; Recurrence; Triazoles; Voriconazole | 2006 |
[Bilateral proximal cellulitis and onychomycosis in both big toes due to Fusarium solani].
Topics: Antifungal Agents; Cellulitis; Ciclopirox; Diabetes Mellitus, Type 2; Disease Susceptibility; Drug Resistance, Multiple, Fungal; Foot Dermatoses; Fusarium; Humans; Imidazoles; Immunocompetence; Itraconazole; Male; Middle Aged; Mozambique; Onychomycosis; Pyridones; Pyrimidines; Recurrence; Toes; Travel; Triazoles; Urea; Voriconazole | 2006 |
Optimal use of aromatase inhibitors: to lead or to follow?
Topics: Aged; Alleles; Anastrozole; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Disease-Free Survival; Female; Humans; Middle Aged; Nitriles; Postmenopause; Receptors, Estrogen; Recurrence; Tamoxifen; Treatment Outcome; Triazoles | 2007 |
Managing Candida endophthalmitis (Recurrent Candida albicans endophthalmitis in an immunocompromised host. Vol. 42[1]).
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Endophthalmitis; Eye Infections, Fungal; Humans; Immunocompromised Host; Postoperative Complications; Pyrimidines; Recurrence; Triazoles; Voriconazole | 2007 |
Recurrent Trichosporon asahii glossitis: a case report.
Topics: Administration, Inhalation; Adult; Antifungal Agents; Asthma; Bronchodilator Agents; Budesonide; Drug Resistance, Fungal; Glossitis; Humans; Immunocompromised Host; Male; Mycoses; Pyrimidines; Recurrence; Triazoles; Trichosporon; Voriconazole | 2008 |
Drug craving and other negative reactions after abrupt substitution of nefazodone for other serotonergic agents.
Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Drug Administration Schedule; Female; Fluoxetine; Humans; Male; Paroxetine; Piperazines; Recurrence; Serotonin Agents; Substance-Related Disorders; Triazoles; Venlafaxine Hydrochloride | 1996 |
Treatment of severe postmenopausal endometriosis with an aromatase inhibitor.
Topics: Administration, Oral; Anastrozole; Animals; Aromatase; Aromatase Inhibitors; Biopsy; Endometriosis; Enzyme Inhibitors; Female; Humans; Middle Aged; Nitriles; Polymerase Chain Reaction; Postmenopause; Rats; Recurrence; RNA, Messenger; Time Factors; Triazoles | 1998 |
Long-term treatment of recurrent and chronic depression.
Topics: Antidepressive Agents; Chronic Disease; Clinical Trials as Topic; Cognitive Behavioral Therapy; Combined Modality Therapy; Cost of Illness; Depressive Disorder; Disability Evaluation; Drug Administration Schedule; Fluoxetine; Humans; Piperazines; Placebos; Recurrence; Treatment Outcome; Triazoles | 2001 |
New breast cancer drug.
Topics: Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Enzyme Inhibitors; Estrogens; Female; Humans; Letrozole; Nitriles; Postmenopause; Recurrence; Triazoles; United States | 2001 |
Inhibition of cyclic flow variations and reocclusion after thrombolysis in dogs by a novel antagonist of platelet-activating factor.
Topics: Administration, Oral; Animals; Benzodiazepines; Bleeding Time; Blood Coagulation; Blood Flow Velocity; Coronary Thrombosis; Disease Models, Animal; Dogs; Drug Therapy, Combination; Hemodynamics; Partial Thromboplastin Time; Platelet Activating Factor; Platelet Aggregation; Platelet Count; Prothrombin Time; Recurrence; Tissue Plasminogen Activator; Triazolam; Triazoles | 1991 |
Persistent Cryptococcus neoformans infection of the prostate after successful treatment of meningitis. California Collaborative Treatment Group.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Drug Therapy, Combination; Fluconazole; Humans; Male; Meningitis; Prostatic Diseases; Recurrence; Triazoles; Urine | 1989 |